Evotec completes £55.7 million Cyprotex acquisition
Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise
Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises
Essential IR Insights Newsletter - Summer July-August 2023
Insight Weekly: Climate law faces hurdles; US borrowing surges; banks revise uninsured deposits
Evotec AG completed its previously announced acquisition of Cyprotex PLC for £55.7 million in cash, including debt.
The purchase is expected to boost Evotec's revenues by €18 million to €20 million in 2017 while also helping the company's EBITDA for the year.
